Drug Recalls

Here you'll find every drug recall the FDA has issued, including prescription medications, over-the-counter drugs, compounded pharmacy products, and dietary supplements. We've been tracking these since 2006 and our database updates several times a day so you're always looking at current information.

Drugs get recalled for a number of reasons: contamination during manufacturing, incorrect potency or dosage, failed quality testing (like dissolution or stability tests), sterility problems in injectable products, or labeling and packaging errors that could cause someone to take the wrong dose. If you find a product on this list that you use, please follow the instructions provided by the FDA to take the necessary precautions.

17,529 total recalls
0 this month

Showing 7941–7960 of 17,529 recalls

November 26, 2018· Tris Pharma Inc.

Recalled Item: Infants' Ibuprofen

The Issue: Superpotent Drug: recalled lots may have higher concentration

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
November 26, 2018· Tris Pharma Inc.

Recalled Item: Infants' Ibuprofen

The Issue: Superpotent Drug: recalled lots may have higher concentration

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
November 21, 2018· QuVa Pharma, Inc.

Recalled Item: Norepinephrine 8 mg (32 mcg/mL) added to 0.9% Sodium Chloride

The Issue: Incorrect excipient: Product was compounded in 250 mL

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
November 20, 2018· Mylan Pharmaceuticals Inc.

Recalled Item: Amlodipine and Valsartan Tablets

The Issue: CGMP Deviations: FDA lab confirmed presence an impurity,

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
November 20, 2018· Mylan Pharmaceuticals Inc.

Recalled Item: Amlodipine and Valsartan Tablets

The Issue: CGMP Deviations: FDA lab confirmed presence an impurity,

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
November 20, 2018· Mylan Pharmaceuticals Inc.

Recalled Item: Amlodipine and Valsartan Tablets

The Issue: CGMP Deviations: FDA lab confirmed presence an impurity,

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
November 20, 2018· Mylan Pharmaceuticals Inc.

Recalled Item: Valsartan Tablets

The Issue: CGMP Deviations: FDA lab confirmed presence an impurity,

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
November 20, 2018· Mylan Pharmaceuticals Inc.

Recalled Item: Valsartan Tablets

The Issue: CGMP Deviations: FDA lab confirmed presence an impurity,

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
November 20, 2018· Mylan Pharmaceuticals Inc.

Recalled Item: Valsartan Tablets

The Issue: CGMP Deviations: FDA lab confirmed presence an impurity,

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
November 20, 2018· Mylan Pharmaceuticals Inc.

Recalled Item: Valsartan and Hydrochlorothiazide Tablets

The Issue: CGMP Deviations: FDA lab confirmed presence an impurity,

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
November 20, 2018· Mylan Pharmaceuticals Inc.

Recalled Item: Valsartan Tablets

The Issue: CGMP Deviations: FDA lab confirmed presence an impurity,

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
November 20, 2018· AVKARE Inc.

Recalled Item: Germ Bloc Health Hand Sanitizer Foam (benzalkonium chloride 0.13%)...

The Issue: Microbial Contamination of Non-Sterile Product: Presence of Pseudomonas

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
November 19, 2018· Pharm D Solutions, LLC

Recalled Item: Human Chorionic Gonadotropin 3000 IU

The Issue: Lack of Assurance of Sterility: Inadequate processes and

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
November 16, 2018· CAO Group, Inc.

Recalled Item: SHEER DesenZ Desensitizing Treatment

The Issue: cGMP violations noted during the firm's most recent

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
November 16, 2018· CAO Group, Inc.

Recalled Item: fas.TRACT Coagulative Hemostatic Gel

The Issue: cGMP violations noted during the firm's most recent

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
November 16, 2018· CAO Group, Inc.

Recalled Item: FastStat Topical Hemostat Introductory Kit

The Issue: cGMP violations noted during the firm's most recent

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
November 16, 2018· CAO Group, Inc.

Recalled Item: BeeGentle Honey Flavored Topical Anesthetic

The Issue: cGMP violations noted during the firm's most recent

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
November 15, 2018· Fresenius Kabi USA, LLC

Recalled Item: SODIUM CHLORIDE INJECTION

The Issue: Labeling Not Elsewhere Classified: Fresenius Kabi is taking

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardTerminated
Refund
November 15, 2018· Fresenius Kabi USA, LLC

Recalled Item: SODIUM CHLORIDE INJECTION

The Issue: Labeling Not Elsewhere Classified: Fresenius Kabi is taking

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardTerminated
Refund
November 14, 2018· Ascend Laboratories LLC

Recalled Item: Quetiapine Tablets USP 400 mg

The Issue: Presence of Foreign Substance; metal shard found in

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund